Genworth Financial (GNW) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net income was $76 million ($0.17 per share), with adjusted operating income of $125 million ($0.28 per share), led by strong Enact performance and strategic progress.
Enact contributed $165 million in adjusted operating income, with Genworth receiving $63 million in capital from Enact during the quarter.
CareScout Quality Network expanded to over 40 states, now covering more than two-thirds of the U.S. 65+ population, targeting 80–85% by year-end.
$36 million in share repurchases executed in Q2, $111 million year-to-date through July 31, 2024; outstanding shares reduced by 15% since May 2022.
Continued progress on LTC multi-year rate action plan, with $138 million in gross incremental premium approvals and $29.2 billion NPV achieved from in-force rate actions since 2012.
Financial highlights
Enact's adjusted operating income rose 13% year-over-year to $165 million, driven by favorable reserve releases and investment income.
Primary insurance in force at Enact increased 3% year-over-year to $266 billion; new insurance written fell 10% year-over-year.
Net investment income for Q2 2024 was $808 million, up 3% year-over-year; net investment losses were $61 million, mainly due to unrealized losses.
U.S. life insurance companies' RBC ratio improved to 319% as of June 30, 2024, up from 314% in March.
Holding company cash and liquid assets totaled $281 million at quarter-end.
Outlook and guidance
Enact expects to return $300–$350 million to shareholders in 2024; Genworth anticipates $245–$285 million based on its 81% stake.
Share repurchase allocation for 2024 increased to $150–$170 million, up from prior guidance.
Management plans to invest $35 million in CareScout in 2024 and file the first CareScout Insurance product.
New LTC funding product launch targeted for 2025, aiming to address unmet consumer demand.
Expectation that LTC paid claims will continue to increase as the block ages, with peak claim years more than a decade away.
Latest events from Genworth Financial
- Proxy details 2025 performance, capital returns, and key votes on directors, pay, and auditor.GNW
Proxy filing24 Mar 2026 - Enact drove Q4 profits and capital returns; CareScout expanded as LTC losses weighed on results.GNW
Q4 202524 Feb 2026 - Q3 net income rose to $85M, driven by Enact strength, LTC actions, and CareScout growth.GNW
Q3 202415 Jan 2026 - Q1 2025 net income was $54M, driven by Enact, CareScout growth, and capital returns.GNW
Q1 202523 Dec 2025 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025 - Strong 2024 results, expanded aging care, and key governance proposals drive shareholder value.GNW
Proxy Filing1 Dec 2025 - Board recommends approval of all key proposals, including director elections and compensation.GNW
Proxy Filing1 Dec 2025 - Q2 2025 net income was $51M, with $94M in capital returns and CareScout network expansion.GNW
Q2 202516 Nov 2025